Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the “Agreement“) with the Manitoba Liquor and Lotteries Corporation(“MBLL“) to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in Manitoba’s adult-use market. “We are thrilled... Read more
In recent laboratory testing, Lexaria’s breakthrough discovery evidenced greatly enhanced drug delivery to brain tissue. Nicotine in-vivo (animal) studies showed that up to 560% more nicotine was delivered to brain tissue utilizing DehydraTECHTM than concentration-matched controls lacking DehydraTECHTM enhancements. The study provided evidence of surprising effectiveness in crossing the blood-brain barrier (“BBB”) which the... Read more
Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has been approved as a supplier of cannabis for the province of Manitoba... Read more
Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V)(M5BQ.F)(NXTTF) is pleased to announce signing of a Master Services Agreement (the “Agreement”) with YPB Group Ltd. (“YPB”)(YPB.AX), an Australian based product verification and customer engagement company. Namaste has identified the need for its global customers to have confidence in the products... Read more
The marijuana market has continued to show a large amount of promise over the course of the past year or so. With new legislation going into place around North America and the world, it seems as though the cannabis industry is just now getting started. Momentum during the past... Read more
Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer”), a leading cannabis technology platform, announced today that it has reported annual website traffic growth to Leafbuyer.com of 375%. Leafbuyer’s new session numbers also grew nearly 30% from March 2018. The growth comes after the company rolled out its new product directory and added major search functionality... Read more
Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today announced positive top-line data from the adaptive Phase 2/3 trial of I.V. CR845 in patients undergoing abdominal surgeries. At the... Read more
THE GREEN ORGANIC DUTCHMAN ANNOUNCES CLOSING OF $25 MILLION SPECIAL WARRANT BOUGHT DEAL FINANCING The Green Organic Dutchman Holdings Ltd. has closed its bought deal financing of 3.91 million special warrants of the company at $6.40 per special warrant for aggregate gross proceeds of approximately $25-million, previously announced on... Read more
The marijuana industry has continued to astound investors as new companies have continued to come to light attracting a myriad of investors into the space. Because of the new legislation and the changing public sentiment toward the favor of cannabis, many new companies have come to light over the... Read more
